Synthesis, characterization, and antimicrobial activity of an ampicillin-conjugated magnetic nanoantibiotic for medical applications
Open Access
- 1 August 2014
- journal article
- Published by Taylor & Francis in International Journal of Nanomedicine
- Vol. 9, 3801-14
- https://doi.org/10.2147/ijn.s61143
Abstract
Because of their magnetic properties, magnetic nanoparticles (MNPs) have numerous diverse biomedical applications. In addition, because of their ability to penetrate bacteria and biofilms, nanoantimicrobial agents have become increasingly popular for the control of infectious diseases. Here, MNPs were prepared through an iron salt coprecipitation method in an alkaline medium, followed by a chitosan coating step (CS-coated MNPs); finally, the MNPs were loaded with ampicillin (amp) to form an amp-CS-MNP nanocomposite. Both the MNPs and amp-CS-MNPs were subsequently characterized and evaluated for their antibacterial activity. X-ray diffraction results showed that the MNPs and nanocomposites were composed of pure magnetite. Fourier transform infrared spectra and thermogravimetric data for the MNPs, CS-coated MNPs, and amp-CS-MNP nanocomposite were compared, which confirmed the CS coating on the MNPs and the amp-loaded nanocomposite. Magnetization curves showed that both the MNPs and the amp-CS-MNP nanocomposites were superparamagnetic, with saturation magnetizations at 80.1 and 26.6 emu g-1, respectively. Amp was loaded at 8.3%. Drug release was also studied, and the total release equilibrium for amp from the amp-CS-MNPs was 100% over 400 minutes. In addition, the antimicrobial activity of the amp-CS-MNP nanocomposite was determined using agar diffusion and growth inhibition assays against Gram-positive bacteria and Gram-negative bacteria, as well as Candida albicans. The minimum inhibitory concentration of the amp-CS-MNP nanocomposite was determined against bacteria including Mycobacterium tuberculosis. The synthesized nanocomposites exhibited antibacterial and antifungal properties, as well as antimycobacterial effects. Thus, this study introduces a novel ß-lactam antibacterial-based nanocomposite that can decrease fungus activity on demand for numerous medical applications.Keywords
This publication has 45 references indexed in Scilit:
- Antibacterial Activities of Liposomal Linolenic Acids against Antibiotic-Resistant Helicobacter pyloriMolecular Pharmaceutics, 2012
- Coping with antibiotic resistance: combining nanoparticles with antibiotics and other antimicrobial agentsExpert Review of Anti-infective Therapy, 2011
- Sustained Antibacterial Activity of Doxycycline-Loaded Poly( D , L -Lactide-Co-Glycolide) and Poly(ε-Caprolactone) NanoparticlesNanomedicine, 2009
- The Bacteria Fight BackPublished by American Association for the Advancement of Science (AAAS) ,2008
- Characterization of Biophysical and Metabolic Properties of Cells Labeled with Superparamagnetic Iron Oxide Nanoparticles and Transfection Agent for Cellular MR ImagingRadiology, 2003
- Intercalation compounds of hydrotalcite-like anionic clays with anti-inflammatory agents, II: Uptake of diclofenac for a controlled release formulation.2002
- Forty years of beta-lactam researchJournal of Antimicrobial Chemotherapy, 1998
- Clinical experiences with magnetic drug targeting: a phase I study with 4'-epidoxorubicin in 14 patients with advanced solid tumors.1996
- Treatment of experimental salmonellosis in mice with ampicillin-bound nanoparticlesAntimicrobial Agents and Chemotherapy, 1989
- "Penbritin": An Oral Penicillin with Broad-spectrum ActivityBMJ, 1961